Teladoc Health, Inc. Hires New CFO Michael Grasher

What Happened

• Teladoc Health, Inc. announced the hiring of Michael Grasher as Chief Financial Officer, effective August 31, 2026. The appointment was disclosed in an 8-K filed August 31, 2026 and accompanied by a company press release.
• Mr. Grasher (age 61) joins from prior CFO roles including IFG Companies (Feb 2024–Sep 2025) and Fortegra Group (Oct 2015–Feb 2024). He holds an MBA from the University of Chicago Booth School of Business and a B.S. from the University of Illinois. Charles Divita, III will continue as Chief Executive Officer.

Key Details

• Compensation package: annual base salary of $550,000 and a one-time sign-on bonus of $500,000. He is eligible for an annual bonus targeted at 85% of base salary beginning for 2027.
• Equity award: a new-hire incentive award with an aggregate target value of approximately $3,000,000 expected to be granted Sept. 1, 2026 — 50% restricted stock units (RSUs) and 50% performance stock units (PSUs). RSUs vest half at 1 year, remainder over six quarterly installments beginning month 15. PSUs are tied to 2026 adjusted EBITDA and revenue CAGR for 2026–2028 with specified vesting dates.
• Severance and change-of-control protections: if terminated without cause or for good reason (outside 12 months after a change of control), he is eligible for 12 months’ base salary, pro rata bonus, any earned prior-year bonus, up to 12 months of continued health premiums, and accelerated service-based vesting for 12 months post-termination (performance awards remain subject to performance). If qualifying termination occurs within 12 months after a change of control, benefits increase (18 months’ salary and health coverage, 100% of target annual bonus as a lump sum, and immediate vesting of service-based equity).
• Other terms: customary 12‑month post‑termination non‑compete/non‑solicit restrictions and a standard indemnification agreement. Company reports no related‑party transactions with Mr. Grasher.

Why It Matters

• This is a material executive hire that restores a permanent CFO after an interim period, and it clarifies Teladoc’s financial leadership going forward. For investors, the filing details the guaranteed cash costs (base and sign‑on) and potential future equity dilution tied to the ~$3M award and ongoing equity programs.
• The employment agreement establishes severance and change‑of‑control protections that create potential future cash and equity obligations. The disclosed performance metrics (adjusted EBITDA and revenue CAGR) show the company’s incentive focus for the CFO role. The press release is filed as Exhibit 99.1 to the 8‑K.